Public COA audit

Tesamorelin

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
88%
Panels
2/7
Purity (printed)
99.71%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
TES202601
Identity method
HPLC with retention time (RT) and spectral matching
Issue date
2026-01-06

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    RT match 1.00-1.02, Spectral match 1000

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.71% average across three vials

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Not on this COA · core

    LAL or chromogenic endotoxin assay.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed across three vials

    Average purity 99.71% (range 99.699-99.713%) with consistent results across triplicate samples, which is normal for research-grade peptides

  • Identity confirmed by dual methods

    Both retention time matching (1.00-1.02) and spectral analysis (1000 match score) confirm Tesamorelin identity

  • Batch number present

    Client SID TES202601 clearly documented

  • Sample date not specified

    COA shows publication date 2026-01-06 but no explicit sample collection or receipt date

  • Laboratory information complete

    TrustPointe Analytics LLC with full contact details, verification URL (TrustPointeLIMS.com), and verification key DKUBGCR943N7

  • Limited testing scope

    Only identity and purity panels performed; no heavy metals, microbial, endotoxin, sterility, or residual solvent testing documented

  • Professional presentation

    Well-formatted COA with triplicate analysis, system suitability data (0.4% RSD), dual signatures, and photo attachment of tested vials

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.